Selective Histone Deacetylase Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 3, 2012-01 ,pp. : 247-270

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

By          

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2908-2912

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells

By    

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1238-1244

Spandidos Publications

Access to resources Recommend Favorite

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer

By Shi Yi-kang   Li Zhong-hua   Han Xi-qian   Yi Ji-hu   Wang Zhen-hua   Hou Jing-li   Feng Cong-ran   Fang Qing-hong   Wang Hui-hui   Zhang Peng-fei   Wang Feng-shan   Shen Jie   Wang Peng  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1131-1140

Springer Publishing Company

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Design, Structure-Activity Relationships and Therapeutic Implications for Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 6, 2009-07 ,pp. : 661-692

Bentham Science Publishers

Access to resources Recommend Favorite